Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-10-19
2009-11-17
Ouspenski, Ilia (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S130100
Reexamination Certificate
active
07619069
ABSTRACT:
TGF-beta 1 binding compositions and reagents related thereto are provided. Methods of using such compositions for therapeutic purpose are also provided.
REFERENCES:
patent: 6492497 (2002-12-01), Thompson et al.
patent: 6906026 (2005-06-01), Noble et al.
patent: 2005/0049403 (2005-03-01), Thompson et al.
patent: 2005/0124534 (2005-06-01), Noble et al.
patent: 2006/0286105 (2006-12-01), Ledbetter et al.
patent: 2007/0148170 (2007-06-01), Desjarlais et al.
patent: WO 97/13844 (1997-04-01), None
patent: WO 00/40227 (2000-07-01), None
patent: WO 00/66631 (2000-11-01), None
patent: WO 2004/098637 (2004-11-01), None
patent: WO 2005/010049 (2005-02-01), None
patent: WO 2005/097832 (2005-10-01), None
patent: WO 2005120437 (2005-12-01), None
patent: WO 2006037029 (2006-04-01), None
Benigni, et al. “Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.” J. Am. Soc. Nephrol. vol. 14 (7) 2003, pp. 1816-1824.
Border, et al., “Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.” Nature, vol. 346 (6282) 1990, pp. 371-374.
Cheng Jingfei et al: “Transforming growth factor-beta signal transduction and progressive rental disease.” Experimental Biology and Medicine, vol. 227 (11) 2002, pp. 943-956.
Flanders K C et al: “Antibodies To Peptide Determinants In Transforming Growth Factor Beta And Their Applications” Biochemistry, American Chemical Society, vol. 27, 1988, pp. 739-746.
Lucas C, et al., “The Autocrine Production of Transforming Growth Factor-Beta1 During Lumphocyte Activation a Study With a Monoclonal Antibody-Based Elisa”, Journal of Immunology, The Williams and Wilkins Co., vol. 145, 1990, pp. 1415-1422.
Shah, et al., “Neutralisation of TGF-beta1 and TGF-beta2 or exogenous addition of TGF-beta3 to cutaneous rat wounds reduces scarring” J. Cell Science, vol. 108 (Pt 3) 1995, pp. 985-1002.
Shehata Medhat et al., “TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia,” Journal of Clinical Investigation, vol. 113, (5) 2004, pp. 676-685.
Ziyadeh, et al., “Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.” Proc. Natl. Acad. Sci. U.S.A. vol. 97(14) 2000, pp. 8015-8020.
“Monoclonal anti-TGTF-b1 antibody,” R&D System Ordering Information, No. mab2401, Jan. 29, 2003.
Davies Julian
Dickinson Craig Duane
Marquis David Matthew
Tang Ying
Vaillancourt Peter Edward
Cohen Charles E.
Eli Lilly and Company
Ouspenski Ilia
Sharp Robert L.
LandOfFree
Antibodies to TGF-beta 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to TGF-beta 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to TGF-beta 1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4144152